This is the PrivCo Investor Profile for Aravis SA
This profile is intended to help you find and contact investors, see private market deal activity, and view private company ownership for the investor Aravis SA.
To unlock all information in this profile: Upgrade to PrivCo Premium

Aravis SA

What's included with your PrivCo Premium Subscription:
Next Actions on Aravis SA:
View Deal ActivityView Direct E-mail Contacts

Investor Summary

Aravis SA is a Zurich, Switzerland-based venture capital firm. Founded in 2001, Aravis SA considers seed and early stage investments.

Investor Overview

Basic Information

Investor Type:Venture Capital
Year Founded:2001
Address:Lehfrauenweg 10
City:Zurich
Country:Switzerland
Phone:View
Fax:View
Website:www.aravis.ch

Investment Preferences

Preferred Stage:Seed
Early Stage
Mid Stage / Expansion

Investor Contacts

Below are direct e-mail contacts for senior professionals at Aravis SA.
Full contact details are available with a PrivCo Premium Subscription.
Upgrade to PrivCo Premium Subscription Instant Full Site-Wide Access
Currently 50% Off Until May. 31!
NameTitle
Jacques R. EssingerVenture Partner
Johanna HolldackVenture Partner
Rolf ZinkernagelVenture Partner
Andreas JacobsPartner and CFO
Oliver ThalmannPartner
Jean-Philippe TripetManaging Partner
Simon NebelManaging Partner
Martin MeilerInvestment Manager

Private Deal History

This table is intended to portray Aravis SA PrivCo-covered market activity. Click below for Deal Details and Private Company Reports.
All data before 2006 is completely free to view! To access data from 2006 onward:
Upgrade to PrivCo Premium Subscription Instant Full Site-Wide Access
Currently 50% Off Until May. 31!
DateTargetTarget IndustryDeal TypeTotal Deal AmountStatus
Feb. 2012ViewTechnologyFundingViewCompletedDetails
Oct. 2010ViewPharmaceutical Research & Drug DiscoveryFundingViewCompletedDetails
Oct. 2010ViewBiotechnologyFundingViewCompletedDetails
Jul. 2010ViewPharmaceutical Research & Drug DiscoveryFundingViewCompletedDetails
May. 2009ViewBiotechnologyFundingViewCompletedDetails
Apr. 2009ViewBiotechnologyFundingViewCompletedDetails
Jan. 2009ViewPharmaceutical Research & Drug DiscoveryFundingViewCompletedDetails
Feb. 2007ViewBiochemicals
Pharmaceuticals		FundingViewCompletedDetails
Aug. 2006ViewBiotherapeuticsAcquisitionViewCompletedDetails
Mar. 2005Borean PharmaBiotechnologyFundingUnspecifiedCompletedDetails

Supplemental Resources

For additional information on Aravis SA, or on private company investing, you can see the following:
What's included with your PrivCo Premium Subscription:
Next Actions on Aravis SA:
View Deal ActivityView Direct E-mail Contacts
  • Learn More About PrivCo
  • PrivCo’s Clients Include:
  • Clients Include: Motorola, 3M, Samsung, Oracle, TATA, Johnson and Johnson, CB Richard Ellis
  • PrivCo Is Featured In:
  • Featured In: The New York Times, New York Post, Bloomberg, CNBC, NPR, The Washington Post, The Wall Street Journal, CNN, Fortune, BusinessWeek, Reuters, CBS News, USA Today
PrivCo’s 300-page Private Company Tech M&A Report for 2012 - Click Here For Full Report
  • Quick Investor Search

within miles
Go to Advanced Search
  • What is PrivCo?

PrivCo is the authority for financial & business data on major private market investors, including:

PrivCo Private Deals Newsletter.
It's FREE!

This is the PrivCo Investor Profile for Aravis SA
This profile is intended to help you find and contact investors, see private market deal activity, and view private company ownership for the investor Aravis SA.
To unlock all information in this profile: Upgrade to PrivCo Premium